2Kessler CM.New products for managing inhibitors to coagulation factors:a focus on recombinant factor Ⅶa concentrate[J].Curr Opin Hematol,2000,7(6):408
3Aitken MG.Recombinant factor Ⅶa[J].Emerg Med Australas 2004,16(5～6):446
4Bishop P,Lawson J.Recombinant biologic for treatment of bleeding disorder[J],Nature,2004 8(3):684
5Elinav E,Ben-Dov I,Hai-Am E,et al.The predictive value of admission and follow up factor Ⅴ and Ⅶ level in patients with acute hepatitis and coagulopathy[J].Hepatology,2005,42(1):82
6Dutton RP,Hess JR,Scalea TM.Recombinant factor Ⅶa forcontrol of hemorrhage:early experience in critically ill trauma patients[J].J Clin Anesth,2003,15(3):184
7Kubisz P,Stasko J.Recombinant activated factor Ⅶ in patient at high risk of bleeding[J].Hematology,2004,9(5～6):317
8Cakdwell SH,Chang C,Macik BG.Recombinant activated factor Ⅶ as a hemostatic agent in liver disease:a break from convention in need of controlled trial[J].Hepatilogy,2004,39(3):592
9Tonda R,Galan AM,Dino M,et al.Hemostatic effect of activated recombinant factor Ⅶ in liver disease:studies in an in vitro model[J].Hepatology,2003,39(6):954
10Bosch J,Thabat D,Bendtsen F,et al.Recombinant factor Ⅶa for upper gastro intestinal bleeding in patients with cirrhosis:a randomized,double-blind trial[J].Gastroenterology,2004,127(4):1123
